Company profile for CancerVAX

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CancerVAX is a pre-clinical biotechnology company developing immunotherapy cancer treatments that use the body’s immune system to fight cancer. We aim to develop transformative therapies to protect and improve people’s lives.By leveraging cutting-edge bioengineering and molecular technologies, we are on a quest to develop a breakthrough Universal Cancer Vaccine. Similar to the way COVID-19 vaccines train the body to recogn...
CancerVAX is a pre-clinical biotechnology company developing immunotherapy cancer treatments that use the body’s immune system to fight cancer. We aim to develop transformative therapies to protect and improve people’s lives.By leveraging cutting-edge bioengineering and molecular technologies, we are on a quest to develop a breakthrough Universal Cancer Vaccine. Similar to the way COVID-19 vaccines train the body to recognize and destroy the coronavirus, we are developing a universal cancer vaccine that uses the body’s immune system to detect, mark and destroy cancer cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
351 Paseo Nuevo, Floor 2 Santa Barbara, CA 93101
Telephone
Telephone
(805) 356-1810
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/14/3165901/0/en/CancerVax-Precision-Therapy-Successfully-Avoids-Healthy-Liver-Cells.html

GLOBENEWSWIRE
14 Oct 2025

https://www.globenewswire.com/news-release/2025/09/03/3143313/0/en/Legendary-Scientist-and-Biotech-Veteran-Joins-CancerVax-as-Strategic-Advisor.html

GLOBENEWSWIRE
03 Sep 2025

https://www.globenewswire.com/news-release/2025/08/26/3138996/0/en/CancerVax-Achieves-Major-Milestones-and-Files-Foundational-Patent-Application.html

GLOBENEWSWIRE
26 Aug 2025

https://www.globenewswire.com/news-release/2025/08/19/3135430/0/en/Scientists-Discuss-the-Recent-CancerVax-Breakthrough.html

GLOBENEWSWIRE
19 Aug 2025

https://www.globenewswire.com/news-release/2025/08/05/3127054/0/en/CancerVax-Successfully-Disguises-Cancer-Cells-and-Tricks-Immune-Cells-into-Attacking-Them.html

GLOBENEWSWIRE
05 Aug 2025

https://www.globenewswire.com/news-release/2025/06/19/3102031/0/en/CancerVax-Nanoparticle-Successfully-Targets-Cancer-Cells-While-Sparing-Non-cancerous-Cells.html

GLOBENEWSWIRE
19 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty